Bayer and Titan: Spheramine cell therapy discontinued Bayer and Titan have stopped development of their cell-based therapy for Parkinson's disease.Bayer has discontinued development of Spheramine due to a failed Phase IIb trial.Spheramine is a cell-based therapy in which human retinal...
Titan's Trial in Parkinson's Disease Misses Endpoints Byline: Catherine Hollingsworth, Staff Writer Wall Street's high hopes for Titan Pharmaceutical Inc.'s Spheramine for Parkinson 's disease were dashed Wednesday when the South San Francisco-based company reported disappointing results...
Titan's Phase IIb Parkinson's study fails end point The Phase IIb trial was designed to explore the safety, tolerability and efficacy of Spheramine, the company's novel cell-based therapy for the potential treatment of moderate to advanced Parkinson 's disease.Marc Rubin, president...
Men Less Likely to Visit Doctors Cancer has taken Tom Hiatt down a long road.Sunglasses Keep Eyes Healthy Sunglasses are not just for the beach anymore.
Wherever we are, our eyes need protection from irritating glare and dangerous UV rays.
Runners: Beware of Getting...
Bayer dumps Titan drug on mid-stage failure Titan Pharmaceuticals announced this morning that its Parkinson 's drug Spheramine failed to hit primary and secondary endpoints in a Phase IIb trial for moderate to advanced Parkinson 's disease.Researchers said there was no...
Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues Introduction As advances in omics technologies enable the development of high value molecular diagnostics, neurological conditions represent an attractive target for diagnostic companies.In this report, Datamonitor identifies the diseases...
TopAbstracts in Parkinson's 07/02/2008 TopAbstracts in Parkinson's are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer...
Life in the Balance: From Brigham and Women's staff cardiologist to Parkinson's patient Boston, MA - A renowned cardiologist with prestigious academic and clinical credentials has written a new book regarded by some as required medical reading.The book, however, is not standard educational fare, but rather an unflinching...
Spotlight Placed On Putamen Puzzle In Parkinson And Pure Autonomic Failure CHICAGO-Patients with pure autonomic failure (PAF) may lose as many dopaminergic neurons in the substantia nigra as do people with Parkinson disease (PD), a new study presented here in April at the AAN annual meeting suggests.The...
Titan's Trial in Parkinson's Disease Misses Endpoints Wall Street's high hopes for Titan Pharmaceutical Inc.'s Spheramine for Parkinson 's disease were dashed Wednesday when the South San Francisco-based company reported disappointing results from a Phase IIb trial of the drug.
Titan Parkinson's treatment fails trial, likely to be dropped by Bayer Schering Titan Pharamceutical Inc.'s potential cell-based treatment for Parkinson 's Disease failed in a Phase IIb study, the company said Wednesday, and likely won't be continued by partner Bayer Schering Pharma.South San Francisco-based...
Titan Parkinson's treatment fails trial, likely to be dropped by Bayer Schering Titan Pharmaceutical Inc.'s potential cell-based treatment for Parkinson 's Disease failed in a Phase IIb study, the company said Wednesday, and likely won't be continued by partner Bayer Schering Pharma.South San Francisco-based...
Titan Parkinson's treatment fails trial, likely to be dropped by Bayer Schering Titan Pharamceutical Inc.'s potential cell-based treatment for Parkinson 's Disease failed in a Phase IIb study, the company said Wednesday, and likely won't be continued by partner Bayer Schering Pharma.South San Francisco-based...
Titan Parkinson's treatment fails trial, likely to be dropped by Bayer Schering Titan Pharamceutical Inc.'s potential cell-based treatment for Parkinson 's Disease failed in a Phase IIb study, the company said Wednesday, and likely won't be continued by partner Bayer Schering Pharma.South San Francisco-based...
[external] Titan Parkinson's treatment fails trial, likely to be dropped by Bayer Schering Silicon Valley / San Jose Business Journal - by Ron Leuty Related News Titan Pharmaceuticals hires ex-Bayer exec as CEO [San Francisco] Avid Radiopharmaceuticals in deal with Bayer Schering [Philadelphia] Onmark inks supply deals with Pfizer...
Phytopharm Plc: Interim Management Statement for 3 Months Ended 30 June 2008 -Phytopharm plc (PYM: London Stock Exchange) ('Phytopharm' or the 'Company') is today issuing its Interim Management Statement ('IMS') which relates to the three month period from 1 April 2008 to 30 June 2008 and contains information up to...
Harvard researchers turn on brain stem cells Biomed Notebook: RNAi drives more than just local science labs [February 25, 2008] Harvard Medical School scientists have discovered molecules in the brain that can turn stem cells into neurons and repair damaged tissue, which could lead to...
From the BIO floor: Bay State touts patents, NIH funding BioTrove and partner win NIH grant for better cancer genetic test [July 2, 2008] Patrick puts pen to $1B Life Sciences Law [June 16, 2008] Immunetics wins $1.2M from NIH to fight resistant bacteria [June 6, 2008] Cambria changes name,...
BioTrove and partner win NIH grant for better cancer genetic test From the BIO floor: Bay State touts patents, NIH funding [June 16, 2008] Immunetics wins $1.2M from NIH to fight resistant bacteria [June 6, 2008] Cambria changes name, announces $5.4M VC round [April 22, 2008] MIT: Stem cells from skin...
German shares close lower led by tech, pharma stocks; banks cap losses UPDATE German shares closed lower with technology and pharmaceuticals leading the way among decliners while gains in financial stocks helped cap losses after Deutsche Bank said it expects to post a profit in the second quarter.The DAX closed...
Half-price IVF hailed a success More than half of the women who took part are pregnantA scheme offering half-price IVF for women who donate their eggs to research has been hailed a success.The Newcastle NHS Fertility Centre at Life selected 12 women to take part in the...
Genetically engineered tobacco can save lives Instead of killing people, tobacco plants are being used to mass-produce cheaper vaccines that will better protect against hepatitis B and cervical cancer, halt gastroenterological norovirus infections and - in the future - even improve the...
Dodgy doctor prescribes breast cancer drugs to men GEORGIA WATERS A Brisbane doctor who illegally prescribed cheap breast cancer drugs to men has offered to pay back nearly $30,000 her patients received in government health subsidies.General practitioner and author Dzung Price, 40, faced...
Dodgy doctor prescribes breast cancer drugs to men GEORGIA WATERS A Brisbane doctor who illegally prescribed cheap breast cancer drugs to men has offered to pay back nearly $30,000 her patients received in government health subsidies.General practitioner and author Dzung Price, 40, faced...
Dodgy doctor prescribes breast cancer drugs to men A Brisbane doctor who illegally prescribed cheap breast cancer drugs to men has offered to pay back nearly $30,000 her patients received in government health subsidies.General practitioner and author Dzung Price, 40, faced Brisbane's...
